Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shukla

Showing results (321-330 of 376) with videos related to

Pageof 38
Sort By:
International Journal of Behavioral Medicine|May 31, 2015
Spirituality, Religiosity, and Health: a Comparison of Physicians' Attitudes in Brazil, India, and IndonesiaGiancarlo Lucchetti, Parameshwaran Ramakrishnan, Azimatul Karimah, et al.
Cancer Discovery|July 4, 2012
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastomaGiannicola Genovese, Ayla Ergun, Sachet A Shukla, et al.
Genome Research|July 7, 2017
Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemiaLili Wang, Jean Fan, Joshua M Francis, et al.
Gynecologic Oncology|October 10, 2025
Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective studyV Garg, E Armstrong, A Celeste, et al.
Science (New York, N.Y.)|September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanomaEliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Pageof 38

Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
International Journal of Behavioral Medicine|May 31, 2015
Spirituality, Religiosity, and Health: a Comparison of Physicians' Attitudes in Brazil, India, and IndonesiaGiancarlo Lucchetti, Parameshwaran Ramakrishnan, Azimatul Karimah, et al.
Cancer Discovery|July 4, 2012
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastomaGiannicola Genovese, Ayla Ergun, Sachet A Shukla, et al.
Genome Research|July 7, 2017
Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemiaLili Wang, Jean Fan, Joshua M Francis, et al.
Gynecologic Oncology|October 10, 2025
Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective studyV Garg, E Armstrong, A Celeste, et al.
Science (New York, N.Y.)|September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanomaEliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Blood|April 30, 2014
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLLLili Wang, Alex K Shalek, Mike Lawrence, et al.
Cell|February 19, 2013
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaDan A Landau, Scott L Carter, Petar Stojanov, et al.
Pageof 38